• Home
  • Store
    • Total Access Subscriptions
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Institutional Site Licenses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • Toolkit
  • FAQs
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Access Purchased Content
Home » Authors » Daniel Carlat, MD

Daniel Carlat, MD

Dr. Carlat has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Articles
Products
  • Articles
  • Products

ARTICLES

Clinical Guidance

Table: Psychiatric Medications in Pregnancy and Lactation

April 24, 2026
Victoria Hendrick, MD and Daniel Carlat, MD

Dr. Hendrick and Dr. Carlat have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

  • Table: Psychiatric Medications in Pregnancy and Lactation

  • Read More
    Fact Sheet

    Use of Psychiatric Medications in Breastfeeding Patients

    April 24, 2026
    Victoria Hendrick, MD and Daniel Carlat, MD

    Dr. Hendrick and Dr. Carlat have no financial relationships with companies related to this material.
    Full Fact Sheet Editorial Information

    When new mothers are admitted to the inpatient psychiatric unit, they might ask about the safety of taking psychiatric medications while breastfeeding.


    Read More
    Fact Sheet

    Depression in Pregnancy: Diagnosis and Treatment

    April 24, 2026
    Victoria Hendrick, MD and Daniel Carlat, MD

    Dr. Hendrick and Dr. Carlat have no financial relationships with companies related to this material.
    Full Fact Sheet Editorial Information

    Prenatal depression is common, affecting 10%–15% of pregnant patients.




    Read More
    Fact Sheet

    PTSD Diagnosis and Treatment

    April 24, 2026
    Victoria Hendrick, MD and Daniel Carlat, MD

    Dr. Hendrick and Dr. Carlat have no financial relationships with companies related to this material.
    Full Fact Sheet Editorial Information

    Many of your patients will most likely have been exposed to significant trauma, such as adverse childhood experiences, domestic or sexual violence, and the hardships associated with homelessness or substance use.



    Read More
    Fact Sheet

    Dissociative Identity Disorder: Diagnosis and Treatment

    April 24, 2026
    Daniel Carlat, MD

    Dr. Carlat has no financial relationships with companies related to this material.
    Full Fact Sheet Editorial Information

    Occasionally you will encounter patients who report having multiple personalities or distinct identities, also called alters. Formerly called “multiple personality disorder,” this condition is now termed dissociative identity disorder (DID). 


    Read More
    Fact Sheet

    Topiramate (Eprontia, Qudexy XR, Topamax, Trokendi XR) Fact Sheet

    April 21, 2026
    Michael Weaver, MD, FASAM, Daniel Carlat, MD, and Talia Puzantian, PharmD, BCPP

    Dr. Carlat, Dr. Weaver, and Dr. Puzantian have no financial relationships with companies related to this material.
    Full Fact Sheet Editorial Information

    Naltrexone, an opioid antagonist, is the first-line medication for alcohol use disorder (AUD)—though it is also approved for opioid use disorder (OUD).




    Read More
    Fact Sheet

    Naltrexone (ReVia, Vivitrol) Fact Sheet

    April 21, 2026
    Michael Weaver, MD, FASAM, Daniel Carlat, MD, and Talia Puzantian, PharmD, BCPP

    Dr. Carlat, Dr. Weaver, and Dr. Puzantian have no financial relationships with companies related to this material.
    Full Fact Sheet Editorial Information

    Naltrexone, an opioid antagonist, is the first-line medication for alcohol use disorder (AUD)—though it is also approved for opioid use disorder (OUD).




    Read More
    Fact Sheet

    Gabapentin (Gralise, Horizant, Neurontin) Fact Sheet

    April 21, 2026
    Michael Weaver, MD, FASAM, Daniel Carlat, MD, and Talia Puzantian, PharmD, BCPP

    Dr. Carlat, Dr. Weaver, and Dr. Puzantian have no financial relationships with companies related to this material.
    Full Fact Sheet Editorial Information

    Gabapentin is effective as an off-label medication to ease alcohol withdrawal symptoms and to reduce cravings over the long term in patients with alcohol use disorder (AUD).




    Read More
    Fact Sheet

    Disulfiram (Antabuse) Fact Sheet

    April 21, 2026
    Michael Weaver, MD, FASAM, Daniel Carlat, MD, and Talia Puzantian, PharmD, BCPP

    Dr. Carlat, Dr. Weaver, and Dr. Puzantian have no financial relationships with companies related to this material.
    Full Fact Sheet Editorial Information

    Disulfiram is an aversive treatment, causing a buildup of ethanol’s metabolite acetaldehyde in the serum, which in turn causes symptoms such as flushing, dizziness, nausea, and vomiting if patient consumes alcohol.



    Read More
    Fact Sheet

    Acamprosate (Campral) Fact Sheet [G]

    April 21, 2026
    Michael Weaver, MD, FASAM, Daniel Carlat, MD, and Talia Puzantian, PharmD, BCPP

    Dr. Carlat, Dr. Weaver, and Dr. Puzantian have no financial relationships with companies related to this material.
    Full Fact Sheet Editorial Information

    Acamprosate is best for maintaining abstinence in patients who have already quit drinking, but it can be helpful even after patients relapse. Naltrexone is the better choice for patients who are still drinking, since it is better at helping patients quit. Acamprosate is preferred over naltrexone in patients with hepatic impairment.


    Read More
    View All Articles by Daniel Carlat, MD

    PRODUCTS

    MFB8e_SpiralCover.png

    Medication Fact Book for Psychiatric Practice, Eighth Edition (2026)

    Daniel Carlat, MD and Talia Puzantian, PharmD, BCPP
    4 Comments
    $99.95

    Updated 2026 prescriber's guide.

    View

    BULK TAX FREE Treating Alcohol Use Disorder: A Fact Book (2023)

    Daniel Carlat, MD, Michael Weaver, MD, Michael Weaver, MD, FASAM, and Talia Puzantian, PharmD, BCPP
    $59.99
    $34.99
    $25.00 (42%)

    All the tools and information needed to assess and treat your patients who are struggling with alcohol use disorder.

    View
    2--Treating-Opioid-Use-Disorder—A-Fact-Book-(2024).png

    Treating Opioid Use Disorder—A Fact Book (2024)

    Daniel Carlat, MD, Noah Capurso, MD, MHS, and Talia Puzantian, PharmD, BCPP
    No Comments
    $44.95

    All the tools you need to assess and treat patients struggling with opioid use disorder. 

    View
    5--Treating-Alcohol-Use-Disorder—A-Fact-Book-(2023).png

    Treating Alcohol Use Disorder—A Fact Book (2023)

    Daniel Carlat, MD, Michael Weaver, MD, FASAM, and Talia Puzantian, PharmD, BCPP
    3 Comments
    $39.99

    All the tools and information needed to assess and treat your patients who are struggling with alcohol use disorder.

    View
    AUDFB1e_CoilBound_Graphic2_transparent_sm.png

    Treating Alcohol Use Disorder: A Fact Book (2023)

    Daniel Carlat, MD, Michael Weaver, MD, FASAM, and Talia Puzantian, PharmD, BCPP
    12 Comments
    $49.99

    All the tools and information needed to assess and treat your patients who are struggling with alcohol use disorder.

    View
    10--The-Medication-Fact-Book-for-Psychiatric-Practice,-Fifth-Edition-(2020).png

    The Medication Fact Book for Psychiatric Practice, Fifth Edition (2020)

    Daniel Carlat, MD and Talia Puzantian, PharmD, BCPP
    No Comments
    $59.95

    A comprehensive reference guide covering all the important facts, from cost to pharmacokinetics, about the most commonly prescribed medications in psychiatry. Includes a 12 CME Post-Test.

    View
    13--Psychiatry-Practice-Boosters,-First-Edition-(2016).png

    Psychiatry Practice Boosters, First Edition (2016)

    Daniel Carlat, MD
    No Comments
    $39.95

    A compilation of research updates with a quick primer on study design and statistics. Includes a 10 CME Post-Test.

    View
    14--Medication-Fact-Book-For-Psychiatric-Practice,-Fourth-Edition-(2018).png

    Medication Fact Book For Psychiatric Practice, Fourth Edition (2018)

    Daniel Carlat, MD and Talia Puzantian, PharmD, BCPP
    No Comments
    $59.95

    A comprehensive reference guide covering all the important facts, from cost to pharmacokinetics, about the most commonly prescribed medications in psychiatry.

    View
    15--Medication-Fact-Book,-Third-Edition-(2016).png

    Medication Fact Book, Third Edition (2016)

    Daniel Carlat, MD and Talia Puzantian, PharmD, BCPP
    No Comments
    $69.95

    101 quick-reference medication fact sheets for the medications you use and are asked about the most. Includes an 8 CME Post-Test.

    View
    16--Drug-Metabolism-in-Psychiatry,-Third-Edition-(2015).png

    Drug Metabolism in Psychiatry, Third Edition (2015)

    Daniel Carlat, MD
    No Comments
    $39.95

    Bridges the gap between the complexities of drug pharmacokinetics and everyday clinical practice. Includes a 6 CME Post-Test.

    View
    View All Products by Daniel Carlat, MD
    Try The New AskCarlat AI

    Ask any clinical question—our AI responds using only the peer-reviewed, editorially vetted content from Carlat Publishing.

    Available In The Carlat Toolkit
    Free Psychiatry Updates
    The latest unbiased psychiatric information sent to your inbox.
    Specify Your Interests
    Featured Book
    • MFB8e_SpiralCover.png

      Medication Fact Book for Psychiatric Practice, Eighth Edition (2026)

      Updated 2026 prescriber's guide.
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2818113403.jpg
      General Psychiatry

      Adult ADHD 1: The Child Grows Up

      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2026 Carlat Publishing, LLC and Affiliates, All Rights Reserved.